Profile data is unavailable for this security.
About the company
AmerisourceBergen Corporation is a global pharmaceutical sourcing and distribution services company. The Company's U.S. Healthcare Solutions segment distributes an offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a wide variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services. This segment consists of Alliance Healthcare, World Courier, Innomar, Profarma, and Profarma Specialty. The Company also focuses on specialty services and a global platform of pharma manufacturer services capabilities.
- Revenue in USD (TTM)247.54bn
- Net income in USD1.62bn
- Incorporated2001
- Employees39.00k
- LocationAmerisourcebergen Corp1 West First AvenueCONSHOHOCKEN 19428United StatesUSA
- Phone+1 (610) 727-7000
- Fax+1 (302) 655-5049
- Websitehttps://www.amerisourcebergen.com/
Mergers & acquisitions
| Acquired company | ABC:NYQ since announced | Transaction value |
|---|---|---|
| PharmaLex Holding GmbH | 14.35% | 1.28bn |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Guangzhou Baiyunshan Phrmcl Hldgs Co Ltd | 10.17bn | 576.03m | 7.85bn | 24.25k | 14.35 | 1.72 | -- | 0.7718 | 2.50 | 2.50 | 44.21 | 20.89 | 1.02 | 6.64 | 4.82 | 2,964,170.00 | 6.16 | 6.40 | 11.92 | 13.40 | 18.34 | 19.37 | 6.03 | 5.93 | 1.41 | -- | 0.3164 | 28.02 | 2.57 | 27.57 | 6.63 | 13.98 | 47.72 | 13.95 |
| Sinopharm Group Co Ltd | 78.02bn | 1.20bn | 10.52bn | 114.77k | 8.73 | 1.09 | 4.03 | 0.1348 | 3.02 | 3.02 | 195.84 | 24.14 | 1.58 | 8.98 | 3.52 | 5,325,268.00 | 4.10 | 4.16 | 17.27 | 17.97 | 8.59 | 8.72 | 2.60 | 2.59 | 1.10 | 5.90 | 0.3874 | 30.03 | 5.97 | 12.36 | 9.89 | 8.86 | 1.26 | 7.54 |
| Shanghai Pharmaceuticals Holding Co Ltd | 34.16bn | 832.84m | 10.70bn | 47.88k | 14.08 | 1.22 | -- | 0.3133 | 1.60 | 1.60 | 66.22 | 18.54 | 1.24 | 7.30 | 3.49 | 5,040,198.00 | 3.82 | 3.90 | 9.42 | 10.17 | 12.87 | 13.67 | 3.07 | 2.86 | 1.09 | 17.36 | 0.388 | 31.20 | 7.49 | 12.13 | 10.28 | 9.79 | 5.99 | 9.93 |
| Cardinal Health Inc | 198.66bn | 463.00m | 21.09bn | 46.50k | 47.40 | -- | 17.52 | 0.1062 | 1.75 | 1.75 | 746.15 | -8.71 | 4.65 | 11.96 | 18.70 | 4,272,301.00 | 1.09 | -1.60 | 3.83 | -3.96 | 3.36 | 4.39 | 0.2341 | -0.4268 | 0.5192 | 14.88 | 1.88 | -- | 11.63 | 6.89 | -252.70 | -- | 0.00 | 1.80 |
| AmerisourceBergen Corp. | 247.54bn | 1.62bn | 34.10bn | 39.00k | 21.64 | 121.01 | 14.59 | 0.1377 | 7.78 | 7.78 | 1,189.74 | 1.39 | 4.27 | 14.73 | 12.21 | 6,347,251.00 | 2.70 | 0.7273 | 11.34 | 2.93 | 3.41 | 3.02 | 0.6327 | 0.1649 | 0.5111 | 11.22 | 0.9061 | 104.71 | 11.50 | 9.27 | 10.32 | 36.05 | 1.25 | 4.74 |
| McKesson Corp | 276.71bn | 3.56bn | 52.61bn | 58.00k | 15.48 | -- | 12.14 | 0.1901 | 25.07 | 25.05 | 1,945.24 | -13.65 | 4.41 | 13.77 | 14.57 | -- | 5.93 | 0.6349 | 26.28 | 2.21 | 4.47 | 5.04 | 1.35 | 0.1611 | 0.513 | 18.46 | 1.36 | 133.57 | 4.83 | 5.84 | 218.41 | -- | -0.7704 | 10.25 |
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Mar 2023 | 20.39m | 10.08% |
| T. Rowe Price Associates, Inc. (Investment Management)as of 31 Mar 2023 | 10.26m | 5.07% |
| BlackRock Fund Advisorsas of 31 Mar 2023 | 8.87m | 4.39% |
| SSgA Funds Management, Inc.as of 31 Mar 2023 | 7.42m | 3.67% |
| JPMorgan Investment Management, Inc.as of 31 Mar 2023 | 6.16m | 3.05% |
| Boston Partners Global Investors, Inc.as of 31 Mar 2023 | 5.01m | 2.48% |
| Fidelity Management & Research Co. LLCas of 31 Mar 2023 | 4.04m | 2.00% |
| Geode Capital Management LLCas of 31 Mar 2023 | 3.39m | 1.68% |
| Bessemer Investment Management LLCas of 31 Mar 2023 | 3.08m | 1.52% |
| BlackRock Investment Management (UK) Ltd.as of 31 Mar 2023 | 2.60m | 1.29% |
